Events
|
2021 |
MAR. |
Received official notification from USFDA that invites BoYen Therapeutics to submit IND for BY-101, for phase 2B clinical trials. |
|
|
FEB. |
Entered into agreement with Taipei World Trade Center International Trade Building, BoYen Therapeutics will relocate to its new premise in May. |
|
|
JAN. |
Contract signed between BoYen Therapeutics and the National Health Research Institutes for BY-102. |
|
|
|
|
|
2020 |
NOV. |
Welcome M. Sherry Ku PhD on board as part of our medical consultant team to assist in the development of drug projects BY-101and BY-102. |
|
|
|
Patents approved by the United States Patent and Trademark Office for BY-102 structural patents and dosage form, this opens the door for the vast market in the treatment of multiple sclerosis. |
|
|
OCT. |
Signed a collaboration/supply agreement with ScinoPharm Taiwan, Ltd, for clinical experimental drugs SPT8278 / BY-101. |
|
|
SEP. |
FDA recommends a small-scale randomized Phase IIB/III clinical trial for BY-101. |
|
|
JUL. |
Completed BY-101 Written-Response-Only Pre-IND meeting with FDA. |
|
|
JUN. |
Awards Bestat Pharmaservices BY-101 clinical protocol contract. |
|
|
|
|
|
2019 |
NOV. |
Completed a Face-to-Face Pre-IND meeting with FDA for BY-101. |
|
|
JAN. |
BY-101 acquired Orphan Drug Designation form FDA. |
|
|
|
|
|
2017 |
OCT. |
New anti-cancer prodrug (BYT-3156) approved by the European Patent Office. |
|
|
JAN. |
New anti-cancer prodrug (BYT-3156) approved by the United States Patent Office. |
|
|
|
|
|
2015 |
JAN |
Approved and designated by the Industrial Development Bureau, MOEA(IDB) as a Biotechnology New Drug Company. |
|
|
|
|
|
2014 |
MAY. |
SBIR Phase 2 approved by the Ministry of Economic Affairs. |
|
|
|
|
|
2013 |
AUG. |
SBIR Phase1 approved by the Ministry of Economic Affairs. |
|
|
|
|
|
2012 |
AUG. |
Laboratory relocates to the Drug Research Center of National Taiwan University, College of Medicine. |
|
|
|
|
|
2010 |
OCT. |
Laboratory set up the Institute of Chemistry, Academia Sinica. |
|
|
JUN. |
BoYen Therapeutics Inc. established in Taipei, Taiwan. |